549 related articles for article (PubMed ID: 25605208)
1. Effects of the CYP2C19 genetic polymorphism on gastritis, peptic ulcer disease, peptic ulcer bleeding and gastric cancer.
Jainan W; Vilaichone RK
Asian Pac J Cancer Prev; 2014; 15(24):10957-60. PubMed ID: 25605208
[TBL] [Abstract][Full Text] [Related]
2. CYP2C19 Genotype, CagA Genotype and Antibiotic Resistant Strain of Helicobacter pylori Infection.
Auttajaroon J; Chotivitayatarakorn P; Yamaoka Y; Vilaichone RK
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1243-1247. PubMed ID: 31030500
[TBL] [Abstract][Full Text] [Related]
3. Poor metabolizer genotype status of CYP2C19 is a risk factor for developing gastric cancer in Japanese patients with Helicobacter pylori infection.
Sugimoto M; Furuta T; Shirai N; Nakamura A; Kajimura M; Sugimura H; Hishida A; Ishizaki T
Aliment Pharmacol Ther; 2005 Nov; 22(10):1033-40. PubMed ID: 16268979
[TBL] [Abstract][Full Text] [Related]
4. CYP2C19*2 polymorphism in Polish peptic ulcer patients.
Sałagacka-Kubiak A; Żebrowska-Nawrocka M; Jeleń A; Mirowski M; Balcerczak E
Pharmacol Rep; 2019 Apr; 71(2):272-275. PubMed ID: 30826566
[TBL] [Abstract][Full Text] [Related]
5. Effects of Genetic Polymorphisms of Cytochrome P450 Enzymes and MDR1 Transporter on Pantoprazole Metabolism and Helicobacter pylori Eradication.
Karaca RO; Kalkisim S; Altinbas A; Kilincalp S; Yuksel I; Goktas MT; Yasar U; Bozkurt A; Babaoglu MO
Basic Clin Pharmacol Toxicol; 2017 Feb; 120(2):199-206. PubMed ID: 27611887
[TBL] [Abstract][Full Text] [Related]
6. Virulence genes of Helicobacter pylori in gastritis, peptic ulcer and gastric cancer in Laos.
Vannarath S; Vilaichone RK; Rasachak B; Mairiang P; Yamaoka Y; Shiota S; Binh TT; Mahachai V
Asian Pac J Cancer Prev; 2014; 15(20):9027-31. PubMed ID: 25374247
[TBL] [Abstract][Full Text] [Related]
7. Correlation of CYP2C19 genetic polymorphisms with helicobacter pylori eradication in patients with cirrhosis and peptic ulcer.
Lay CS; Lin CJ
J Chin Med Assoc; 2010 Apr; 73(4):188-93. PubMed ID: 20457439
[TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori cagL amino acid polymorphism D58E59 pave the way toward peptic ulcer disease while N58E59 is associated with gastric cancer in north of Iran.
Cherati MR; Shokri-Shirvani J; Karkhah A; Rajabnia R; Nouri HR
Microb Pathog; 2017 Jun; 107():413-418. PubMed ID: 28433795
[TBL] [Abstract][Full Text] [Related]
9. Effect of IL-1 Polymorphisms, CYP2C19 Genotype and Antibiotic Resistance on Helicobacter pylori Eradication Comparing Between 10-day Sequential Therapy and 14-day Standard Triple Therapy with Four-Times-Daily-Dosing of Amoxicillin in Thailand: a Prospective Randomized Study.
Phiphatpatthamaamphan K; Vilaichone RK; Siramolpiwat S; Tangaroonsanti A; Chonprasertsuk S; Bhanthumkomol P; Pornthisarn B; Mahachai V
Asian Pac J Cancer Prev; 2016; 17(4):1903-7. PubMed ID: 27221874
[TBL] [Abstract][Full Text] [Related]
10. CYP2C19 genotype-related efficacy of omeprazole for the treatment of infection caused by Helicobacter pylori.
Tanigawara Y; Aoyama N; Kita T; Shirakawa K; Komada F; Kasuga M; Okumura K
Clin Pharmacol Ther; 1999 Nov; 66(5):528-34. PubMed ID: 10579481
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Pro12Ala PPAR gamma polymorphism and Helicobacter pylori infection in gastric adenocarcinoma and peptic ulcer disease.
Prasad KN; Saxena A; Ghoshal UC; Bhagat MR; Krishnani N
Ann Oncol; 2008 Jul; 19(7):1299-1303. PubMed ID: 18372284
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori and the risk and management of associated diseases: gastritis, ulcer disease, atrophic gastritis and gastric cancer.
Kuipers EJ
Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():71-88. PubMed ID: 9146793
[TBL] [Abstract][Full Text] [Related]
13. Up-regulated CCL18, CCL28 and CXCL13 Expression is Associated with the Risk of Gastritis and Peptic Ulcer Disease in Helicobacter Pylori infection.
Sanaei MJ; Shirzad H; Soltani A; Abdollahpour-Alitappeh M; Shafigh MH; Rahimian G; Mirzaei Y; Bagheri N
Am J Med Sci; 2021 Jan; 361(1):43-54. PubMed ID: 32928496
[TBL] [Abstract][Full Text] [Related]
14. The EPIYA-ABCC motif pattern in CagA of Helicobacter pylori is associated with peptic ulcer and gastric cancer in Mexican population.
Beltrán-Anaya FO; Poblete TM; Román-Román A; Reyes S; de Sampedro J; Peralta-Zaragoza O; Rodríguez MÁ; del Moral-Hernández O; Illades-Aguiar B; Fernández-Tilapa G
BMC Gastroenterol; 2014 Dec; 14():223. PubMed ID: 25539656
[TBL] [Abstract][Full Text] [Related]
15. The clinical role of cytochrome p450 genotypes in Helicobacter pylori management.
Sapone A; Vaira D; Trespidi S; Perna F; Gatta L; Tampieri A; Ricci C; Cantelli-Forti G; Miglioli M; Biagi GL; Paolini M
Am J Gastroenterol; 2003 May; 98(5):1010-5. PubMed ID: 12809821
[TBL] [Abstract][Full Text] [Related]
16. Effects of CYP2C19 and MDR1 genotype on the eradication rate of Helicobacter pylori infection by triple therapy with pantoprazole, amoxycillin and clarithromycin.
Oh JH; Dong MS; Choi MG; Yoo HW; Lee SB; Park YI; Chung IS
J Gastroenterol Hepatol; 2009 Feb; 24(2):294-8. PubMed ID: 18823430
[TBL] [Abstract][Full Text] [Related]
17. Helicobacter pylori cagA and iceA genotypes status and risk of peptic ulcer in Saudi patients.
Momenah AM; Tayeb MT
Saudi Med J; 2007 Mar; 28(3):382-5. PubMed ID: 17334464
[TBL] [Abstract][Full Text] [Related]
18. Peptic ulcer bleeding: is Helicobacter pylori a risk factor in an endemic area?
Sotoudehmanesh R; Asgari AA; Fakheri HT; Nouraie M; Khatibian M; Shirazian N
Indian J Gastroenterol; 2005; 24(2):59-61. PubMed ID: 15879651
[TBL] [Abstract][Full Text] [Related]
19. Effect of CYP2C19 Gene Polymorphisms on Proton Pump Inhibitor, Amoxicillin, and Levofloxacin Triple Therapy for Eradication of Helicobacter Pylori.
Lin YA; Wang H; Gu ZJ; Wang WJ; Zeng XY; Du YL; Ying SS; Zhang BH
Med Sci Monit; 2017 Jun; 23():2701-2707. PubMed ID: 28577017
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori infection, glandular atrophy, intestinal metaplasia and topography of chronic active gastritis in the Nepalese and Japanese population: the age, gender and endoscopic diagnosis matched study.
Matsuhisa T; Miki M; Yamada N; Sharma SK; Shrestha BM
Kathmandu Univ Med J (KUMJ); 2007; 5(3):295-301. PubMed ID: 18604043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
